首页> 美国卫生研究院文献>Springer Open Choice >Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective 2-Year Follow-Up Observational Post-Marketing Study

【2h】

Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective 2-Year Follow-Up Observational Post-Marketing Study

机译：常规临床实践中的2型糖尿病患者使用利拉鲁肽的有效性和持续性-证据：一项为期2年的随访观察上市后研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionThe aim of this study was to investigate whether the efficacy of liraglutide observed in randomized controlled trials translates into therapeutic benefits in the French population during routine clinical practice.

机译：引言这项研究的目的是研究在常规临床实践中，在随机对照试验中观察到的利拉鲁肽的疗效是否转化为法国人群的治疗益处。

著录项

期刊名称 Springer Open Choice
作者
Jean-Francois Gautier; Luc Martinez; Alfred Penfornis; Eveline Eschwège; Guillaume Charpentier; Benoît Huret; Suliya Madani; Pierre Gourdy;
展开▼
作者单位

展开▼
年(卷),期 -1(32),9
年度 -1
页码 838–853
总页数 16
原文格式 PDF
正文语种
中图分类外科学;
关键词
BMI Liraglutide Observational Type 2 diabetes Weight;

机译：体重指数;利拉鲁肽;观察型;2型糖尿病;体重;

相似文献

外文文献
中文文献
专利

1. Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice-EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study [J] . Gautier Jean-Francois, Martinez Luc, Penfornis Alfred, Advances in therapy. . 2015,第9期

机译：常规临床实践中证据表明，利拉鲁肽在2型糖尿病患者中的有效性和持续性：证据：一项为期2年的随访，观察，上市后研究
2. Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India [J] . Subhash Kumar Wangnoo, Surender Kumar, Arpandev Bhattacharyya, Indian Journal of Endocrinology and Metabolism . 2016,第6期

机译：利拉鲁肽在糖尿病患者中的作用和作用（LEAD-In）：一项前瞻性观察性研究，评估利拉鲁肽在印度常规临床实践条件下治疗的2型糖尿病患者中的安全性和有效性
3. Metabolic effectiveness of gliflozins and gliptins in the routine clinical practice of patients with type 2 diabetes: preliminary results from GIOIA, a prospective multicentre study [J] . Esposito Katherine, Longo Miriam, Maiorino Maria Ida, Diabetes research and clinical practice . 2019,第期

机译：Gliflozins和Plipins在2型糖尿病患者常规临床实践中的代谢效果：Gioia的初步结果，一项潜在的多期面研究
4. Clinical Practice Guidelines Consistency for Patients with Multimorbidity: a Case-Study in the Management of Type 2 Diabetes and Hypertension [C] . Alexre GALOPIN, Jacques BOUAUD, Suzanne PEREIRA, Medical Informatics in Europe Conference. . 2015

机译：多药物患者的临床实践指导方针：2型糖尿病和高血压管理的案例研究
5. Evaluation of the effectiveness of Sertoli cells to suppress immune responses for the potential use as a safer alternative to systemic immune suppression in clinical islet transplantation for the treatment of type 1 diabetes [D] . Lord, Sarah Jean 2005

机译：评价血液细胞抑制免疫应答的潜在用途的潜在用途，作为临床胰岛移植在临床胰腺移植中的含有型1型糖尿病的替代品
6. Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study a Prospective 2-Year Follow-up Observational Post-Marketing Study [O] . Luc Martinez, Alfred Penfornis, Jean-Francois Gautier, -1

机译：利拉鲁肽治疗在二级保健和专科治疗的2型糖尿病患者中的有效性和持续性：证据研究的一项亚组分析一项前瞻性2年随访观察上市后研究
7. Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study [O] . 2015

机译：常规临床实践中的2型糖尿病患者使用利拉鲁肽的有效性和持续性-证据：一项为期2年的随访，观察，上市后研究

Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective 2-Year Follow-Up Observational Post-Marketing Study

摘要

著录项

相似文献

相关主题

期刊订阅